Press Releases Enhabit, Inc.

Equities

Market Closed - Nyse Other stock markets 04:00:02 2024-05-21 pm EDT			5-day change	1st Jan Change
9.27 ^USD	+3.58%		+2.54%	-10.43%

May. 14	Leerink Partners Upgrades Enhabit to Market Perform From Underperform, Price Target is $8.50	MT
May. 10	UBS Trims Price Target on Enhabit to $9 From $10, Keeps Neutral Rating	MT

Enhabit Announces Participation in Upcoming Goldman Sachs 45th Annual Global Healthcare Conference	May. 21	BU
Enhabit Announces Participation in Upcoming Leerink Partners Healthcare Crossroads Conference 2024	May. 20	BU
AREX Capital Expresses Disappointment in Enhabit’s Strategic Review Conclusion	May. 09	AQ
Enhabit: Q1 Earnings Snapshot	May. 08	AQ
Enhabit Concludes Review of Strategic Alternatives	May. 08	BU
Enhabit Reports First Quarter 2024 Financial Results	May. 08	BU
Enhabit Home Health & Hospice Announces Date of 2024 First Quarter Earnings Call	Apr. 10	BU
Enhabit Home Health & Hospice Named a Winner of the 2024 Top Workplaces USA Award	Mar. 20	BU
Enhabit : Q4 Earnings Presentation	Mar. 06	PU
Enhabit: Q4 Earnings Snapshot	Mar. 06	AQ
Enhabit Reports Fourth Quarter Results and Issues Full-Year 2024 Guidance	Mar. 06	BU
Enhabit Home Health & Hospice Announces Date of 2023 Fourth Quarter Earnings Call	Feb. 08	BU
Enhabit: Q3 Earnings Snapshot	Nov. 07	AQ
Enhabit Reports Third Quarter 2023 Financial Results	Nov. 07	BU
Arex Capital Issues Letter to Board of Directors of Enhabit, Inc.	23-10-05	AQ
Enhabit Home Health & Hospice Announces Date of 2023 Third Quarter Earnings Call; Comments on Limited Waiver and Liquidity	23-10-04	BU
Enhabit Home Health & Hospice Confirms Exploration of Strategic Alternatives to Enhance Stockholder Value	23-08-23	BU
AREX Capital Issues Letter to Board of Directors of Enhabit, Inc.	23-08-14	AQ
Enhabit : Q2 Earnings Presentation	23-08-10	PU
Enhabit: Q2 Earnings Snapshot	23-08-09	AQ

No results for this search